Share
10 min read
communityEvidence-based

186 posts, 50+ experiments, 1 mission: What Phoenix members are testing this month

Should you try phospholipid DHA? Is Alpha GPC worth it? What about those fishy omega-3s? Phoenix members are testing everything and sharing real results.

T
· Reviewed by Dr. Kevin Tran, PharmD

Key takeaways · TL;DR

Phoenix Community members generated 186 posts and 50+ experiments in a month, testing interventions including phospholipid DHA, Alpha GPC, rapamycin, methylene blue, statin plus ezetimibe, and 20g creatine. Discussions covered ALZ-801 trial updates, shingles and RSV vaccines dementia benefits, VO2max optimization, and p-tau217 biomarker tracking for APOE4 carriers.

Definition

An oral prodrug of tramiprosate designed to prevent toxic amyloid beta oligomer formation, developed for APOE4/4 Alzheimer patients.

ALZ-801 is notable for targeting the homozygous APOE4 population historically disadvantaged in amyloid-clearing antibody trials, and for oral delivery without infusion requirements.

Definition

A form of omega-3 DHA bound to phospholipids that may cross the blood-brain barrier more efficiently than triglyceride-form fish oil.

Phoenix members compare phospholipid DHA products like Lysoveta to standard fish oil for brain-specific omega-3 delivery, especially relevant for APOE4 carriers with impaired DHA transport.

Exercise Intensity Zones Discussed by Phoenix Members

ZoneIntensityPrimary Adaptation
Zone 2Moderate, conversational paceMitochondrial density, fat oxidation, aerobic base
Zone 4/5Hard to maximal effort intervalsVO2max, cardiac output, lactate threshold

Looking at the Phoenix Community discussions from the past month, I'm struck by the sheer depth and variety of what our members are exploring together.

Let me give you a glimpse inside our community.

The conversations that matter most

Cutting-edge research discussions are lighting up our forums.

Members are diving deep into the latest APOE4 breakthroughs: from protective variants that block Alzheimer's through different mechanisms to memory reversal studies that challenge everything we thought we knew. The ALZ-801 trial updates have sparked particularly intense debate about prodrug approaches for 4/4 carriers.

But here's what makes Phoenix different: we don't just read the studies. We dissect them. Question them. Apply them.

Real-world supplement experimentation dominates our threads.

Should you use phospholipid-form DHA? What about Alpha GPC as a "no regret" supplement? Members are sharing actual results from their rapamycin trials, methylene blue experiments, and statin protocols. One member's 90-day lipid transformation on statins and ezetimibe triggered a cascade of insights about personalized approaches to cholesterol management.

The cooking oil debate alone generated dozens of evidence-based perspectives (spoiler: it's more nuanced than you think).

Exercise optimization gets precision-focused.

VO2max improvements from 37 to 50 in 7 months? Check. Zone 2 vs Zone 4/5 training protocols? Hotly debated. Members aren't just exercising: they're optimizing based on their genetics, tracking results, and sharing what actually moves the needle.

The emotional journey gets equal attention.

"You're not alone—this space is for the emotional side of the journey" perfectly captures our ethos. From advance directive planning to dealing with PET scan results showing substantial plaque buildup, members support each other through the tough moments with both empathy and actionable advice.

Accountability drives action.

Weekly goal threads keep members on track. But these aren't your typical "drink more water" goals. Members are tracking p-tau217 levels, running structured supplement experiments, and measuring cognitive improvements from intensive lifestyle changes.

Why this matters

Every single day, Phoenix members are:

  • Testing interventions most doctors haven't heard of yet

  • Sharing biomarker results that inform everyone's protocols

  • Supporting each other through diagnosis, testing, and optimization

  • Translating complex research into real-world action

We are NOT a passive support group. It's an active laboratory of people determined to beat the odds.

The conversations you're missing could change your trajectory.

While you're reading this, someone in Phoenix is sharing their successful protocol for improving hippocampal blood flow. Another is decoding the latest research on glymphatic system enhancement. A third is getting encouragement to finally start that exercise program they've been putting off.

Ready to join these conversations?

We're selective about who joins: because the quality of our community depends on it. But if you're serious about taking control of your brain health future, you belong here.

See you inside,
Kevin

P.S. Next week, members are diving into the new estrogen and brain health research, comparing direct-access testing options by state, and experimenting on sleep optimization techniques. Don't miss out.

All discussions from the past month:

🧬 Research

  • Latest on ALZ-801 trial

  • Large POINTER study finds cognitive improvements with intensive structured lifestyle changes

  • We have to put this controversy to rest once and for all

  • Deep dive into 3 protective APOE variants that block Alzheimer's

  • How to lower APOB

  • Huge study showing benefits of two common vaccines, Shingles and RSV

  • Interesting article from Peter Attia on inducing ketosis

  • Suvorexant

  • AD clinical studies

  • The Overlooked Role of Protein in APOE4 and Alzheimer's Prevention

  • Your Ancestry Changes How ApoE4 Works: 3 Breakthroughs

  • Reevaluating the role of education on cognitive decline

  • What I learned from Rhonda Patrick's analysis

  • APOE4: Scientists reversed memory loss + found social factors override genetics

  • APOE ε4 carriers share immune-related proteomic changes

  • Anyone tried Dr Goodenowe's ProdromeScan?

  • 3X4 Genetics- Memory and Brain Health Snps

  • New ApoE4 Science About Estrogen and Brain Health!

  • Small human pilot study shows 20g creatine supplementation improved brain energetics

  • ApoE4 & Alzheimer's: 11 New Discoveries That Changed My Game Plan

  • Vaccines and dementia

  • (Small) study says intense lifestyle changes can not only stop but even reverse Alzheimer's

  • ApoE4? New Brain Protection Breakthroughs Every Carrier Must See

  • Varicose veins and dementia

  • Ezetimibe for prevention

💊 Supplements, Nutrition, and Medication

  • What oil do you use for cooking?

  • Could Statins Be Our Secret Weapon Against Dementia?

  • Update on Lipids after 90 days on statin and ezetimibe

  • Online Source for peptides

  • These Omega-3s, they smell fishy...

  • Next Intervention - Rapamycin

  • Phospholipid-form DHA - what do you use?

  • Methylene Blue?

  • Choline (Alpha GPC), big "no regret" supplement

  • I Have Stopped Taking Ezetimibe

  • My view about keto: not adapted when doing 12h+ of sport per week

  • Has anyone used Saffron?

  • Microdosing Semiglutide

  • Nut Pods Y or N

  • Protein Bars

  • LPC-DHA (Lysoveta)

  • Dairy fat, Cheese, Cream.. Are they all equally bad for LDL-C?

  • Cholesterol medication?

  • Ursolic acid

  • Quality control on Supplement brands

  • Psyllium husk - For fiber and tactical use to blunt absorption

  • Cure for Alzheimer's?

  • Is Alcohol good or bad for you? In moderation or not at all?

  • Anyone with experience with Kisunla (donanemad-azbt)?

  • Modified Citrus Pectin (MCP) and stress reduction

  • What do you do to keep lipids under control?

🏃 Sports, Sleep, and Stress Management

  • Finally focusing on VO2 Max / Zone 4/5 Training

  • Sleep Optimization Sleep Trackers Research & More, Matthew Walker Interview

  • What sports / activities do you do?

  • Neuroplasticity Thread

  • Sleep optimization with mouth taping

  • Outsized effect interventions for brain clarity / avoiding brain fog

  • Factors affecting sleep - mystified

  • When I found out I had APOE4/4, my brain played tricks on me

  • NSDR - Non Sleep Deep Rest

  • VO2max from 37 to 50 in 7 months

🔬 Biomarkers, Tracking, Monitoring

  • Lipoprotein(a) (Lp(a))

  • Cost of beta amyloid 40/42 and p-tau217 tests

  • Klotho may really help..

  • Obicetrapib - Delayed Progression p-Tau217

  • Any experience with Care Access screenings?

  • Direct-Access Testing by U.S. State

  • Cholesterol Balance Test Hyper absorb or Hyper produce

🧠 Mental Health & Emotional Resilience

  • You're not alone — this space is for the emotional side of the journey

  • URGH! I'm overwhelmed and burnt out.

  • PET scan results indicate BAPL3, indicating substantial plaque build up

💻 Tech and Medical Devices

  • Brain Health Dosing with Red Light Therapy

  • Red Light Therapy

  • Wearables

🧬 Genetics

  • My Genetics

🎯 Goals and Accountability

  • July 28-August 11 Weekly Goals and Accountability Thread

  • July 21-28 Weekly Goals Support and Accountability Thread

  • July 14-21 Weekly Goals and Accountability Thread

  • July 7 -14 Goals and Accountability Weekly Thread

  • June 30 Goals and Accountability Weekly Thread

  • June 23rd Weekly Goals and Accountability Thread

📢 Announcements

  • Your Phoenix Monthly Check-In Just Got Smarter (And Way More Personal)

  • Shape the Ultimate Personalized APOE4 Protocol: Decide Which Features Matter to You!

  • June update: Vote for our new look!

  • [Action Needed] June Monthly Check-In Time!! Remember to fill yours!

🎁 Perks and Partnerships

  • Whole Genome Sequencing: Nucleus

  • Whole Genome Sequencing: Sequencing.com

📔 Open Journal

  • New Experiment with Methylene Blue!

🤝 General and Off Topic

  • Opening address for Thurs July 31, 2025 at AAIC

  • AAIC presentation: The Importance of Early Detection

  • Handgrip study

  • Blacked out 1 week of memory after taking meds for muscle / nerve injury

  • Labcorp vs Quest

  • Alzheimer's Association International Conference, Toronto, Canada

  • Made a Decision on Kisnula Today

  • Long Term Care insurance - especially USA

  • Increase in T-p-tau181

  • Advanced Directive (More than Medical!)

Discussion

Join the conversation

Your email will never be published. Be respectful and constructive.

FAQ

Frequently asked questions.

What supplements are APOE4 carriers testing in The Phoenix Community?
Phoenix members actively experimented with phospholipid-form DHA, Alpha GPC as a no-regret choline supplement, methylene blue, rapamycin, LPC-DHA (Lysoveta), saffron, microdosed semaglutide, and 20 grams of creatine which a small human pilot showed improved brain energetics. Members also tested statin plus ezetimibe combinations and shared 90-day lipid transformation data. Rather than one-size-fits-all recommendations, they share individual results including dose, duration, biomarker changes, and side effects so other APOE4 carriers can calibrate their own protocols.
What is ALZ-801 and why are APOE4 carriers watching it?
ALZ-801 (valiltramiprosate) is an oral prodrug being developed specifically for APOE4/4 homozygous Alzheimer patients. It inhibits the formation of toxic amyloid beta oligomers rather than clearing existing plaques. Phoenix members debate ALZ-801 trial updates intensely because it represents one of the few therapeutics designed with APOE4/4 carriers as the primary population, a group historically excluded or disadvantaged in amyloid-targeting antibody trials due to higher ARIA risk. An oral pill with a favorable safety profile would be transformative for daily prevention.
Do shingles and RSV vaccines reduce dementia risk?
Phoenix members discussed a large study showing that common vaccines including shingles and RSV provide measurable dementia risk reduction. The shingles vaccine has been associated with roughly 20 percent lower dementia incidence in previous natural experiments, with stronger effects in women, and RSV vaccination appears to add similar protective signal. Proposed mechanisms include reduced reactivation of latent herpesviruses implicated in Alzheimer pathology and broader modulation of neuroinflammation. Members are weighing vaccination timing as part of their APOE4 prevention strategy.
How much can VO2max improve with structured exercise for APOE4 carriers?
A Phoenix member documented improving VO2max from 37 to 50 over 7 months of structured training, sparking intense debate about optimal protocols. Members discussed Zone 2 steady-state work for mitochondrial density versus Zone 4/5 high-intensity intervals for cardiac output, and how to balance both. VO2max is one of the strongest predictors of all-cause mortality and cognitive resilience, making it a priority biomarker for APOE4 carriers who want objective evidence that their training is producing physiological adaptation rather than just burning calories.
What is the POINTER study and what did it find for cognitive decline?
The POINTER study is a large randomized trial that evaluated whether intensive, structured lifestyle changes including exercise, diet, cognitive training, and vascular risk monitoring could improve cognition in adults at risk for dementia. Phoenix members analyzed results showing cognitive improvements in the structured intervention arm compared to self-guided lifestyle changes. For APOE4 carriers, POINTER reinforced that the combination of interventions delivered with accountability outperforms any single intervention, which maps directly to the Phoenix pod and check-in methodology.
Should you try phospholipid DHA? Is Alpha GPC worth it? What about those fishy omega-3s? Phoenix members are testing everything and sharing real results.
Dr. Kevin Tran August 05, 2025 Looking at the Phoenix Community discussions from the past month, I'm struck by the sheer depth and variety of what our members are exploring together. Let me give you a glimpse inside our community.
Why this matters
Every single day, Phoenix members are: Testing interventions most doctors haven't heard of yet Sharing biomarker results that inform everyone's protocols Supporting each other through diagnosis, testing, and optimization Translating complex research into real-world action We are NOT a passive support group. It's an active laboratory of people determined to beat the odds. The conversations you're missing could change your trajectory. While you're reading this, someone in Phoenix is sharing their successful protocol for improving hippocampal blood flow. Another is decoding the latest research on glymphatic system enhancement. A third is getting encouragement to finally start that exercise program they've been putting off. Ready to join these conversations? Apply to join the Phoenix here → We're selective about who joins: because the quality of our community depends on it. But if you're serious about taking control of your brain health future, you belong here. See you inside, Kevin P.S. Next week, members are diving into the new estrogen and brain health research, comparing direct-access testing options by state, and experimenting on sleep optimization techniques. Don't miss out.
Keep reading

Related protocols.